Medical Biotechnology - University of Illinois

advertisement

Rubric Justification – MBT

4/10/2020

TO:

FROM:

Robert Mrtek, Chair

August 30, 2005

Senate Committee on Educational Policy

Roger Nelson

Assistant Vice Chancellor for Academic Affairs

I am submitting for review and action by the Senate Committee on Educational Policy the attached proposal from the College of Medicine at Rockford to establish a new course subject, MBT (Medical Biotechnology) for the proposed Master of Science in

Medical Biotechnology program.

When the proposal for the M.S. in Biotechnology was considered by the Graduate

College Executive Committee in December 2003 (and tabled by the GCEC), there was a companion proposal to establish the BioT course rubric. That proposal was tabled as well. After many months of rewriting and improving the proposal for the degree, it came back as the M.S. in Medical Biotechnology, which reflected the emphasis of the degree.

The courses attached to the new proposal had the course subject (rubric) of MBT

(Medical Biotechnology). However, a proposal to establish the new MBT course subject was not submitted for review. Hence, the attached proposal is being presented to the

Graduate College Executive Committee for their meeting on September 9, 2005 as well.

I ask that the Senate Committee on Educational Policy review this item and approve it pending Graduate College Executive Committee approval. If the proposal is approved by both committees, it will be considered at the September 29 th

Senate meeting, together with the request for the new MS in Medical Biotechnology degree program.

The Executive Committee at the College of Medicine at Rockford will receive the proposal as an information item at its meeting on September 8. A letter will soon follow from the regional dean. I will inform the Graduate College Executive Committee of the

COM-Rockford’s Executive Committee acknowledgement of the new course subject.

RN:

Attachment

Cc: C. Hulse

J. Art

M. Schechtman

A. Levant

S. Kragon

1 of 4

Rubric Justification – MBT

4/10/2020

August 31, 2005

Dr Roger Nelson

Assistant Vice Chancellor for Academic Affairs

University of Illinois at Chicago

University Hall

Rm2630

601 South Morgan

Chicago, IL 60607-7128

Dear Dr Nelson,

Just a brief note to tell you that I fully support the Rubric proposal of August

18, 2005, for the Masters of Medical Biotechnology (MBT) that we are developing here at the College of Medicine in Rockford. This proposal is very similar to the earlier Rubric proposal (BIOT) for the MS program approved on March 13, 2003. The requested change emphasizes medical biotechnology as the program focus and more clearly indicates the leverage of the Medical School in this program.

The Executive Committee of the College of Medicine at Rockford meets on

September 8 2005, and will offer additional approval of this proposal at that time. Notification of that approval will follow promptly.

Sincerely

Martin Lipsky, MD

Regional Dean

2 of 4

Rubric Justification – MBT

4/10/2020

Title : Establish a New Course Subject (Rubric), MBT (Medical Biotechnology)

Sponsor : Department of Biomedical Sciences,

College of Medicine at Rockford

Description :

This proposal requests the creation of a new course subject (rubric) of “MBT

(Medical

Biotechnology) for the proposed Master of Science in Medical Biotechnology program in the Department of Biomedical Sciences of the U of I College of Medicine at Rockford.

Justification:

The proposed master’s program includes creation of 13 new required and elective courses, leverages one current course from the MPH program and has two MBT courses for master’s projects or research. Because this is a new degree program, the Department is requesting a new rubric for the courses. As indicated, the proposed rubric is MBT .

Catalog Statement :

The new rubric and subjects will appear in the Graduate catalog associated with the course listings. The course listing is attached for information.

Minority Impact : None

Budgetary and Staff Implications :

Creation of the new course subject carries no budgetary implications. Budgetary implications as a result of the establishment of new courses for the proposed M.S. in

Medical Biotechnology program are included in the proposal for that new degree program, which is being processed concurrently for campus approval.

Library Support : None

Unit Approval:

College approval :

Proposed Effective Date : Fall Semester, 2006

3 of 4

Rubric Justification – MBT

4/10/2020

Core Courses:

Listing of New MS in Medical Biotechnology Courses

(For information only)

Required Course

MBT 500 DNA & Proteins

Credit

Hours

3

MBT 501 Cell Biology & Human Physiology

MBT 502 Immunotechnology, Microbiology and Cellular Therapy

MBT 503 Pharmacology, Toxicology and Clinical Trials

MBT 510 Ethics in Biotechnology

MBT 595 Student Seminar in Biotechnology

3

3

3

2

2

BSTT 400 Biostatics I

Elective Courses

Elective Courses

MBT 520 Biotechnology Product Development, Concepts,

Practice & Regulatory Issues

MBT 521 Techniques and Processes in Biotechnology

MBT 522 Applied Medical Biotechnology

MBT 523 Biotechnology Engineering

MBT 594 Special Topics

MBT 596 Independent Study

Research Courses

3

Credit

Hours

2

3

2

2

1-4

1-4

MBT 597 Master’s Project Research (0–16 Credit hours). The Master’s Project consists of a research internship in a biotech company or jointly in a lab at the university and with a company, culminating in a scholarly paper (in the form of a journal article) describing the theoretical and practical considerations of the research work. The article should be of publication quality. At least one semester will be spent working at the internship in industry or in a laboratory at the College of

Medicine at Rockford. The graduate advisory committee will help the student in choosing an appropriate industry partner or laboratory mentor.

MBT 598 Master’s Thesis Research (0–16 credit hours).

The Master’s Thesis is an independent research study in which the student designs the study and carries it out under the supervision of a faculty mentor. The research itself may be carried out in a lab at the university or at a biotechnology company. The research will be started the summer after the first year of classes, and will continue through the second year along with coursework. The finished product will be a thesis in the official “thesis” format.

4 of 4

Download